by Neoteryx | 1 min read
by Neoteryx | 1 min read
The Mitra® microsampling device, based on Volumetric Absorptive Microsampling (VAMS™) technology developed by Neoteryx, is a simple instrument. It collects small, volumetrically accurate specimens of blood (and other biological fluids) and allows for remote sampling, taking blood collection out of the clinic.
This provides blood collection, shipping, and storage solution that is in many respects superior to what came before. What's more interesting is what it means for clinical trials, clinical diagnostics, and the entire spectrum of medical research, precision medicine, patient-centered care, and health and wellness.
This video provides:
See for yourself how blood microsampling is inspiring new conversations, opening new pathways of care, and connecting the potential of new technologies with the stuff of human life.
Originally published Mar 26, 2019 9:20:28 AM, updated on December 6, 2022
Learn about insights, research, case studies, and tutorials on integrating remote specimen collection, microsampling, and more!
Contact Us
Trajan Scientific Americas Inc.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mitra® devices are intended as a specimen collector and for the storage and transport of blood. They are CE-IVD in the UK and EU, a Class 1 IVD in Australia, Brazil & China, Class B in South Africa, and registered with health agencies in Canada and Ukraine.
In the USA, Mitra devices are supplied as a Research-Use Only (RUO) product, to assist in method development, other research-related and non-diagnostic activities. Mitra has not been validated for use with any diagnostic testing. The suitability of Mitra for any analytical application must be evaluated and validated by the laboratory or research institute in a manner consistent with local regulatory requirements.
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research use only (RUO) and not for therapeutic or diagnostic use.
Mitra®, VAMS® & hemaPEN® are registered trademarks owned by entities in the Trajan Group.
Copyright © 2022. All rights reserved.